With 0.65 million shares changed hands, the volume of the stock remained lighter than its average volume of 0.72 million shares. During the session, the Household & Personal Products company that operates in wider Consumer Defensive sector, reached to the highest price of $6.34 whereas the lowest price it dropped to was $5.945. The 52-week range on NUS shows that it touched its highest point at $14.00 and its lowest point at $5.32 during that stretch. It currently has a 1-year price target of $7.50. With its current market cap of 312.76 million, NUS has annualized dividend of $0.24 while the current yield stands at 3.79%. NUS paid its most recent dividend on 1740355200, while the ex-dividend date for that was 1740355200. Beta for the stock currently stands at 0.91.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of NUS was up-trending over the past week, with a rise of 14.67%, but this was down by -12.81% over a month. Three-month performance dropped to -8.26% while six-month performance rose 2.76%. The stock lost -48.58% in the past year, while it has lost -8.13% so far this year.
Float and Shares Shorts:
At present, 49.80 million NUS shares are outstanding with a float of 47.56 million shares on hand for trading. On 2025-04-15, short shares totaled 2.02 million, which was 409.00003 higher than short shares on 1741910400. In addition to Mr. Steven J. Lund J.D. as the firm’s Co-Founder & Executive Chairman of the Board, Mr. Ryan S. Napierski serves as its President, CEO & Director.
Institutional Ownership:
Through their ownership of 0.77182 of NUS’s outstanding shares, institutional investors have minority control over the company.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on 2024-12-31, NUS reported revenue of $445552000.0 and operating income of -$7205000.0. The EBITDA in the recently reported quarter was $10387000.0 and diluted EPS was -$0.73.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for NUS since 0 analysts follow the stock currently. There are 0 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 0 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of $0.68493 being high and $0.65515 being low. For NUS, this leads to a yearly average estimate of $0.675.
